PLPPR4: A Promising Drug Target and Biomarker (G9890)

Target Name: PLPPR4

NCBI ID: G9890

PLPPR4

PLPPR4: A Promising Drug Target and Biomarker

PLPPR4 (Pro-Liotic PeptideRP4) is a protein that is expressed in various human tissues and has been shown to play a role in various biological processes. One of the most promising aspects of PLPPR4 is its potential as a drug target or biomarker. This article will discuss the research on PLPPR4, its potential drug targets, and its potential as a biomarker for various diseases.

PLPPR4 is a 21-kDa protein that is expressed in various human tissues, including the gut, skin, and blood. It is a member of the P-type cation transport protein (P-CSP) family and is localized to the cytoplasm of cultured cells. PLPPR4 is involved in various physiological processes, including cell signaling, stress response, and inflammation.

One of the most promising aspects of PLPPR4 is its potential as a drug target.PLPPR4 has been shown to play a role in various cellular processes, including cell signaling, stress response, and inflammation. Its involvement in these processes makes it an attractive target for drug development.

PLPPR4 has been shown to be involved in cell signaling. PLPPR4 has been shown to be involved in the regulation of T cell responses, which is important for immune surveillance. Studies have shown that PLPPR4 plays a role in the development of T cell tolerance and that its expression is decreased in diseases such as cancer, autoimmune diseases, and obesity. Therefore, PLPPR4 may be a promising target for drugs that are aimed at increasing T cell responses or reducing tolerance to antigens.

PLPPR4 has also been shown to be involved in stress response. PLPPR4 is a stress-responsive protein and has been shown to play a role in the regulation of cellular stress responses. Studies have shown that PLPPR4 is involved in the regulation of DNA damage repair, cell cycle progression, and apoptosis, which are all important aspects of stress response. Therefore, PLPPR4 may be a promising target for drugs that are aimed at preventing or treating stress-related diseases.

PLPPR4 has also been shown to be involved in inflammation. PLPPR4 has been shown to play a role in the regulation of inflammation and has been shown to be involved in the production of pro-inflammatory cytokines. Studies have shown that PLPPR4 is involved in the regulation of immune and inflammatory responses and that its expression is increased in diseases such as rheumatoid arthritis, inflammatory bowel disease, and cancer. Therefore, PLPPR4 may be a promising target for drugs that are aimed at reducing inflammation or treating inflammatory diseases.

PLPPR4 may also be a promising biomarker for various diseases. Its involvement in various physiological processes makes it a potential biomarker for a wide range of diseases. For example, PLPPR4 may be a promising biomarker for cancer, as its expression is often increased in cancer cells. It may also be a promising biomarker for autoimmune diseases, as its expression is often increased in autoimmune disease samples. Additionally, PLPPR4 may be a promising biomarker for obesity, as its expression is often increased in obese samples.

In conclusion, PLPPR4 is a protein that has been shown to play a role in various physiological processes. Its potential as a drug target or biomarker makes it an attractive target for research in the field of pharmacology. Further studies are needed to fully understand its role in cell signaling, stress response, and inflammation, as well as its potential as a biomarker for various diseases.

Protein Name: Phospholipid Phosphatase Related 4

Functions: Postsynaptic density membrane protein that indirectly regulates glutamatergic synaptic transmission through lysophosphatidic acid (LPA)-mediated signaling pathways. Binds lysophosphatidic acid (LPA) and mediates its internalization into cells. Could act as receptor or a transporter of this lipid at the post-synaptic membrane (By similarity). Modulates lysophosphatidic acid (LPA) activity in neuron axonal outgrowth during development by attenuating phospholipid-induced axon collapse (By similarity)

The "PLPPR4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PLPPR4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets